Paul Tudor Jones Gossamer Bio, Inc. Transaction History
Tudor Investment Corp Et Al
- $19.2 Billion
- Q2 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 46,464 shares of GOSS stock, worth $44,605. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,464
Previous 46,464
-0.0%
Holding current value
$44,605
Previous $54,000
24.07%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GOSS
# of Institutions
101Shares Held
175MCall Options Held
453KPut Options Held
543K-
Nea Management Company, LLC Timonium, MD18.1MShares$17.4 Million1.54% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$12.8 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$11.3 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.82 Million1.91% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$7.73 Million4.25% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $90.2M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...